Funded Startups in Park City
Across the 14 most recent Park City entries, the largest disclosed round is Nexus IT Consultants’ $60M on 2025-06-09, and it stands out as the only disclos…
Across the 14 most recent Park City entries, the largest disclosed round is Nexus IT Consultants’ $60M on 2025-06-09, and it stands out as the only disclosed amount above $50M in this slice; the next-largest disclosed values are far lower ($10M or less), including NuView Life Sciences at $90M (2020-08-03) and Oka at $3M (2025-07-01), with multiple $1M and $2M rounds in between. The dataset also shows clear clustering: 6 of the 14 rounds were dated between 2024-06-04 and 2024-10-09, spanning Health Care, Biotechnology, Data and Analytics, and IT.
Stage/amount disclosures are uneven, with “Series Unknown” appearing in 8 of 14 rows and “undisclosed” amounts appearing in 3 of 14, which makes direct size comparisons dependent on the remaining disclosed amounts. Sector-wise, Biotechnology and Health Care each appear multiple times (Biotechnology: Control Medical Technology, Domus Diagnostics, NuView Life Sciences; Health Care: Ouma Health, Ouma Health-adjacent listing entries include CIRCA Scientific and Control Medical Technology’s biotech label; CIRCA Scientific and Ouma Health are explicitly Health Care), while dates run from 2020-02-18 (Huckabuy) through 2025-11-28 (Feasibly).
Most recent rounds
14 shownRelated listings
Frequently asked
Which disclosed round looks like an outlier for Park City, and how does it compare to the rest of the disclosed amounts?
Nexus IT Consultants’ $60M (2025-06-09) is the standout high-water mark within the 2024–2025 cluster and is the only disclosed round above $50M among the 2024–2025 entries (with the next-largest disclosed amounts in that window at $5M or below). Separately, NuView Life Sciences is a historic outlier outside that window with $90M on 2020-08-03, while several 2020–2024 deals sit at $1M–$2M (e.g., Huckabuy $2M on 2020-02-18; Domus Diagnostics $2M on 2023-05-24).
How concentrated are the rounds in time across this Park City list?
There’s a notable mid-period cluster: 6 of the 14 rounds fall between 2024-06-04 (Split Second Research) and 2024-10-09 (Ouma Health). The most recent entry is Feasibly on 2025-11-28 at $1M, while the oldest shown is Huckabuy on 2020-02-18 at $2M, giving a 5-year span in the current slice.
Are ‘Series Unknown’ or ‘undisclosed’ amounts common enough to limit stage or size analysis?
Yes. “Series Unknown” appears in 8 of 14 rows (e.g., Ouma Health on 2024-10-09, CIRCA Scientific on 2024-09-20, and Split Second Research on 2024-06-04), and amounts are explicitly “undisclosed” in 3 of 14 (Ouma Health 2024-10-09; MRP 2024-06-05; Split Second Research 2024-06-04). That means several of the largest comparisons rely only on the remaining disclosed amounts (e.g., Feasibly $1M; Oka $3M; Control Medical Technology $1M; Kodiak Cakes $100K).
Do any sectors appear repeatedly enough to form a recognizable pattern in Park City?
Biotechnology shows up as a recurring label: Control Medical Technology (2024-08-20, $1M), Domus Diagnostics (2023-05-24, $2M), and NuView Life Sciences (2020-08-03, $90M). Health Care also repeats via CIRCA Scientific (2024-09-20, $4M) and Ouma Health (2024-10-09, amount undisclosed), suggesting more life-sciences coverage than the shorter-lived app/commerce categories (e.g., only single entries for Feasibly’s AI/Data and Treads’ Apps in 2023-11-02 at $5M).
Which time window has the most clearly disclosed larger checks, and which entries define that range?
Among the later years, the strongest disclosed range is concentrated around mid-2025: Nexus IT Consultants’ $60M (2025-06-09) and Oka’s $3M (2025-07-01), followed by smaller disclosed rounds like Feasibly $1M (2025-11-28). Earlier highs are less present in the 2021–2022 portion (Kodiak Cakes is $100K on 2022-02-17, and SABX is $1M on 2022-10-24), while the historic peak in the list is NuView Life Sciences at $90M on 2020-08-03.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.